Shinko Asset Management Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Shinko Asset Management Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$22K	Hold	177	–	–	﹤0.01%	729
2016 Q2	$25K	Hold	177	–	–	﹤0.01%	687
2016 Q1	$23K	Hold	177	–	–	﹤0.01%	727
2015 Q4	$25K	Hold	177	–	–	﹤0.01%	713
2015 Q3	$24K	Hold	177	–	–	﹤0.01%	714
2015 Q2	$31K	Sell	177 -23	-12%	-$4.13K	﹤0.01%	584
2015 Q1	$35K	Hold	200	–	–	﹤0.01%	542
2014 Q4	$33K	Buy	+200	New	+$33.2K	﹤0.01%	577

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Shinko Asset Management Company's JAZZ Position: Q3 2016 in Review

Shinko Asset Management Company held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2016 at 177 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Shinko Asset Management Company first reported a position in JAZZ in Q4 2014 and has held it in 8 quarters since. The position peaked at $35K in Q1 2015. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Shinko Asset Management Company held 177 shares of Jazz Pharmaceuticals worth $22K as of Q3 2016.
Shinko Asset Management Company left its Jazz Pharmaceuticals share count unchanged in Q3 2016.
Jazz Pharmaceuticals made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #729 holding.
Shinko Asset Management Company first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 8 quarters since.
Shinko Asset Management Company's Jazz Pharmaceuticals position peaked at $35K in Q1 2015.
326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.